1. Screening for secondary hypertension

   • Mattias Aurell

   Invited Commentary Pages: 461 - 461

2. Web alert

   News Pages: 463 - 464

3. Literature alert

   Abstract Pages: 465 - 467

4. Compliance, quality of life, and cost effectiveness

   • William B. Stason

   Clinical Trials Review Pages: 471 - 474

5. Current studies in pharmacoeconomics

   • J. Jaime Caro

   Clinical Trials Review Pages: 475 - 476

6. Behavior-changing methods for improving adherence to medication

   • Cynthia Willey

   OriginalPaper Pages: 477 - 481

7. Hypertension in multicultural and minority populations: Linkin communication to compliance

   • Joseph R. Betancourt
   • J. Emilio Carrillo
   • Alexander R. Green

   OriginalPaper Pages: 482 - 488

8. Home blood pressure teletransmission for better diagnosis and treatment

   • Thomas G. Pickering
   • William Gerin
   • John K. Holland

   OriginalPaper Pages: 489 - 494

9. Unmet needs in hypertension: Challenges and opportunities

   • Joseph D. Jackson
   • Patrick Merat

   OriginalPaper Pages: 495 - 501

10. Compliance and hypertension

    • Frances B. Garfield
    • J. Jaime Caro

    OriginalPaper Pages: 502 - 506

11. Cardiovascular risk and ambulatory blood pressure

    • William B. White

    ReviewPaper Pages: 509 - 511

12. Controversies surrounding the treatment of the hypertensive patient with diabetes

    • L. Michael Prisant
    • Rita J. Louard

    OriginalPaper Pages: 512 - 520

13. Hypertensive cardiovascular disease in African Americans

    • Ravinder K. Wali
    • Matthew R. Weir

    OriginalPaper Pages: 521 - 528

14. Hypertension in pregnancy: New recommendations for managemen

    • Roberta Shear
    • Line Leduc
    • Jean-Marie Moutquin

    OriginalPaper Pages: 529 - 539

15. Hypertension in patients with pheochromocytoma

    • Nader N. Hanna
    • Daniel E. Kenady

    OriginalPaper Pages: 540 - 545

16. Fibromuscular dysplasia of the renal arteries

    • Andrew Z. Fenves
    • C. Venkata S. Ram

    OriginalPaper Pages: 546 - 549